Status: Recruiting
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
A companion platform trial to test novel targeted agents based on the patient's tumor profile.
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 0-21Biological sex: AllType: InterventionalSponsor: Australian & New Zealand Children's Haematology/Oncology GroupUpdated: Jan 28, 2026Locations: 14
Eligibility criteria
Patients must be diagnosed with a solid tumor, CNS tumor or lymphoma that has pr... [+13]
Patients with symptomatic central nervous system (CNS) primary or metastatic tum... [+7]